Fintel reports that on January 9, 2025, Morgan Stanley upgraded their outlook for Vir Biotechnology (NasdaqGS:VIR) from Equal ...

Bull markets are often built on themes, and it’s clear which one has been driving the current one’s gains. It’s all about AI, ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

Morgan Stanley analysts have outlined a bearish outlook on the Australian banking sector due to record price-to-earnings ...

At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs ...

Oklahoma-based financial advisors John “David” Veitch and his son Drew are joining Raymond James’ employee advisor channel, ...

Morgan Stanley Mortgage Capital Holdings has scheduled a foreclosure auction for the 2.2M SF office park near the ...

Q4 earnings season has the potential to reveal actual progress and results for freight transportation companies, according to ...

Morgan Stanleys Chief US Equity Strategist, Mike Wilson, forecasts a volatile first half of 2025, with recovery prospects ...

The broad-based S&P 500 (SNPINDEX: ^GSPC) returned 23%, the blue-chip Dow Jones Industrial Average (DJINDICES: ^DJI) advanced ...

This week brought yet another twist in the saga around Textor's shareholding in the Premier League club — this is what we ...